What is the equity of Asian Phytoceuticals PCL this year?
Asian Phytoceuticals PCL has equity of 609.7 M THB this year.
In 2024, Asian Phytoceuticals PCL's equity was 609.7 M THB, a 0.28% increase from the 607.98 M THB equity in the previous year.
Asian Phytoceuticals PCL's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Asian Phytoceuticals PCL's equity is essential for assessing its financial health, stability, and value to shareholders.
Evaluating Asian Phytoceuticals PCL's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.
Asian Phytoceuticals PCL's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.
Fluctuations in Asian Phytoceuticals PCL’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.
Asian Phytoceuticals PCL has equity of 609.7 M THB this year.
The equity of Asian Phytoceuticals PCL has increased/decreased by 0.28% increased compared to the previous year.
A high equity is advantageous for investors of Asian Phytoceuticals PCL as it is an indicator of the company's financial stability and its ability to manage risks and challenges.
A low equity can be a risk for investors of Asian Phytoceuticals PCL, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.
An increase in equity of Asian Phytoceuticals PCL can strengthen the company's financial position and improve its ability to make investments in the future.
A reduction in equity of Asian Phytoceuticals PCL can affect the financial situation of the company and lead to a higher dependence on debt capital.
Some factors that can affect the equity of Asian Phytoceuticals PCL include profits, dividend payments, capital increases, and acquisitions.
The equity of Asian Phytoceuticals PCL is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.
To change equity, Asian Phytoceuticals PCL can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.
Over the past 12 months, Asian Phytoceuticals PCL paid a dividend of 0.16 THB . This corresponds to a dividend yield of about 2.77 %. For the coming 12 months, Asian Phytoceuticals PCL is expected to pay a dividend of 0.16 THB.
The current dividend yield of Asian Phytoceuticals PCL is 2.77 %.
Asian Phytoceuticals PCL pays a quarterly dividend. This is distributed in the months of May, May, June, May.
Asian Phytoceuticals PCL paid dividends every year for the past 12 years.
For the upcoming 12 months, dividends amounting to 0.16 THB are expected. This corresponds to a dividend yield of 2.77 %.
Asian Phytoceuticals PCL is assigned to the 'Non-cyclical consumption' sector.
To receive the latest dividend of Asian Phytoceuticals PCL from 5/13/2024 amounting to 0.18 THB, you needed to have the stock in your portfolio before the ex-date on 4/29/2024.
The last dividend was paid out on 5/13/2024.
In the year 2023, Asian Phytoceuticals PCL distributed 0.123 THB as dividends.
The dividends of Asian Phytoceuticals PCL are distributed in THB.
Our stock analysis for Asian Phytoceuticals PCL Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Asian Phytoceuticals PCL Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.